DAWN CH Clinical Haematology Software Newsletter

August 2016 DAWN Haematology Software E-Newsletter
In this issue:
Work smarter - Version 7.9.57

Option to show patient gender in the caption for the patient screen
To aid accurate and easy patient identification, the patient's gender is now displayed in the caption for the patient screen.

Status in treatment plan summary panel of patient screen shows if patient is inactive or deceased
To make it simpler to spot patients who are deceased and to distinguish patients whose record is active and taking up a patient license from those that are inactive and would need reactivating in order to start another course of treatment, DAWN now shows whether the patient is Inactive or Deceased. If they are neither (in other words they are active), it shows the treatment plan status as Stopped.

If a patient is deceased:

If a patient is inactive:

If a patient is still active and taking up a patient license:

If the patient does not have a treatment plan at all then the screen makes this clearer and displays the steps you would need to perform in order to activate the record and commence therapy:

Changes to the Close and Reset button availability
Previous versions of DAWN displayed the Reset button on the patient screen.  This button should not be used during the normal workflow and exists chiefly to help undo a set of results that might have been closed by mistake.  However, its position of prominence has caused some users to press it by mistake and get into a situation where they can no longer see the Close button they need to close a set off results and move the patient to the next appointment.

In version 7.9.57, the Reset button is no longer visible on the main patient screen (it is still accessible from the Details screen should it be needed). By contrast, the Close button is now always available for an open set of tests.

Option to automatically activate a new treatment plan
In previous versions of DAWN, if you stopped a patient’s Treatment Plan and started a new one in order to change their therapy, you had to remember to activate the new Treatment Plan.

In version 7.9.57 you have the option to let DAWN automatically activate a new Treatment Plan once you have selected the Therapy Template.

This functionality is switched off by default but can be enabled by changing the system setting NonAC_TreatmentPlan_AutoActivate to 1.

Please Note: a user must have sufficient user profile permissions to activate treatment plans for auto activate to work.  If a user does not have permission to activate treatment plans, the system behaves as before and requires someone else with sufficient permissions to activate the record manually.

For information on upgrading your DAWN CH system, which is covered under your annual maintenance contract, please contact the 4S DAWN support team at

Resetting your DAWN password - help and guidance

Reset a forgotten password via email
In Version 7.9.44 of DAWN CH, the login screen was redesigned to include the option to reset a forgotten password by email.

If you forget your password, you can simply enter your email address and press the Resetb button. So long as DAWN is configured to send emails and can identify you from your email address, it resets your password automatically and emails you a temporary password that you can use to log in.

When you log in using the temporary password, you are immediately prompted to change your temporary password for a new one of your choosing. The new Change Your Password form is much more helpful than before. It lists the rules which your new password has to meet. As you type, as soon as your password satisfies a rule (e.g. is at least 6 characters long) the red X symbol next to the rule turns to a green  symbol. When all rules show a green tick, you know your new password is sufficiently strong.

To upgrade to the latest version of DAWN CH (Version 7.9.57) and take advantage of this and a range of other user and safety improvements, contact the 4S DAWN support team at

Reset your password via your System Administrator
If you do not have DAWN Version 7.9.44 or above, you should ask your DAWN System Administrator to reset your password.

This is usually a DAWN user who has full admin rights to the system.

Reset your password via DAWN support
Your should reset your password via the DAWN CH system or via your DAWN System Administrator in the first instance.

If you are unable to reset your password via either of these options you can email the 4S DAWN support team at and it can be reset for you.

New questionnaires to improve patient information recording and save time
There are a number of questionnaires available for your DAWN CH system that are designed to accurately record and store patient information, reduce transcribing errors and save you time.

The Questionnaire tab on the patient record stores completed questionnaires, completion date and summary results where appropriate

From Annual Review and Initiation Questionnaires to Clinical Decision Aids and Disease Scores, DAWN questionnaires make it easier to record, store, find and report on key patient information.

For more information on questionnaires for your DAWN CH system, contact the 4S DAWN team at

Using DAWN CH with Internet Explorer Version 9 and 10
If Internet Explorer has been updated on your PC to Version 10 or 11, you may get the following error message when you try to log-in to DAWN:

In order to run the DAWN system in Internet Explorer version 10 or 11, you will need to run it in Compatibility View which requires a change to the settings in Internet Explorer, outlined below:

Update Compatibility Settings
1. Open DAWN CH the usual way
2. Minimise the logon window if it appears
3. You will now see a window like below:

4. Click on the gear symbol in the top right corner (highlighted above)
5. Click Compatibility View Settings
6. Your DAWN address will appear in the 'Add this website' box - press 'Add' (NB it is the first part of the address that you should be prompted to add to the list of websites. For example, if you normally access your DAWN system using the web address path http://mm-file-01/DawnCF76_UK it is the mm-file-01 bit that should be added).

7. Ensure that Use Microsoft compatibility lists is unticked

Update the Trusted Sites
Under “Tools/Internet Options”, click on the “Security” tab, “Trusted Sites”, and then “Sites”, again, make sure your URL (as used in the compatability settings above) is in the list of trusted sites and that the tick box “Require server verification. . . .” is NOT ticked.

Pop-up Blocker
Under “Tools/Internet Options”, click on the “Privacy” tab, make sure that “Turn on Pop-up Blockers"  checkbox is unticked.

After completing the 3 actions above
1. Close the window and all other Internet Explorer windows; and re-open DAWN
2. You should now be able to navigate DAWN without errors

Expand your capabilities with DAWN
As the range of application areas covered by 4S DAWN Clinical Software increases, there has been lots of interest in using DAWN within other departments and many customers now have a number of DAWN systems installed within their hospital/Trust.

The DAWN software now covers the following areas:
  • Alcohol Liaison
  • Anaemia Management
  • Anticoagulation
  • Dermatology
  • Gastroenterology
  • Heart Failure
  • Multiple Sclerosis
  • Respiratory
  • Rheumatology
If you or any of your colleagues would be interested in learning more about any of the areas above, contact the 4S DAWN team today at to discuss your requirements and see a demonstration of the software in action.

Did you know...

AbbVie's venetoclax set for early access in UK
Patients with chronic lymphocytic leukaemia could be eligible for treatment with AbbVie's venetoclax under an early-access scheme.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has looked at the scientific evidence for venetoclax in CLL patients with a hard-to-treat form of the disease, and concluded the drug should be included in the Early Access to Medicines Scheme (EAMS).

Family History Not Associated With Disease Progression in MGUS
A family history of lymphoproliferative disorders is not a risk factor for progression from monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma, a study presented at the European Hematology Association (EHA) 21st Congress.1

Previous research has demonstrated that first-degree relatives of patients with MGUS and multiple myeloma have a 2-fold to 3-fold increased risk of a lymphoproliferative disorder

Imbruvica® (ibrutinib) now available for some patients in Scotland with rare, aggressive and incurable blood cancers
The Scottish Medicines Consortium (SMC) has recommended Imbruvica® (ibrutinib), an oral, once-daily treatment, for use in Scottish patients with specific types of rare and aggressive blood cancers. Ibrutinib has been accepted without restriction for use in patients in Scotland with relapsed or refractory mantle cell lymphoma (MCL) and for restricted use in patients with chronic lymphocytic leukaemia (CLL) with 17p deletion or TP53 mutation who are unsuitable for chemo-immunotherapy

Follow us on our LinkedIn Page!
4S DAWN Clinical Software has a new LinkedIn company page where you can keep up to date with all of the latest news and developments. Follow us and join our LinkedIn community: CLICK HERE

Copyright © 2016 4S Information Systems Ltd, All rights reserved.